Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Microbiologyopen ; 10(2): e1183, 2021 03.
Article in English | MEDLINE | ID: mdl-33970536

ABSTRACT

In recent years, the fermented milk product kefir has been intensively studied because of its health benefits. Here, we evaluated the microbial consortia of two kefir samples, from Escarcega, Campeche, and Campeche (México). We considered a functional comparison between both samples, including fungal and bacterial inhibition; second, we applied shotgun metagenomics to assess the structure and functional diversity of the communities of microorganisms. These two samples exhibited antagonisms against bacterial and fungal pathogens. Bioactive polyketides and nonribosomal peptides were identified by LC-HRMS analysis. We also observed a high bacterial diversity and an abundance of Actinobacteria in both kefir samples, and a greater abundance of Saccharomyces species in kefir of Escarcega than in the Campeche kefir. When the prophage compositions were evaluated, the Campeche sample showed a higher diversity of prophage sequences. In Escarcega, we observed a prevalence of prophage families that infect Enterobacteria and Lactobacillus. The sequences associated with secondary metabolites, such as plipastatin, fengycin, and bacillaene, and also bacteriocins like helveticin and zoocin, were also found in different proportions, with greater diversity in the Escarcega sample. The analyses described in this work open the opportunity to understand the microbial diversity in kefir samples from two distant localities.


Subject(s)
Anti-Infective Agents/metabolism , Anti-Infective Agents/pharmacology , Bacteria/drug effects , Fungi/drug effects , Kefir/microbiology , Metagenome , Animals , Bacteria/classification , Biodiversity , Cultured Milk Products/microbiology , DNA, Bacterial , DNA, Fungal , Fermentation , Food Microbiology , Fungi/classification , Metagenomics/methods , Mexico , Microbiota , Milk/microbiology , Peptides/pharmacology , Polyketides/pharmacology , Prophages/genetics , Secondary Metabolism
2.
Chem Biodivers ; 18(4): e2000820, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33560535

ABSTRACT

We aimed to develop a standardized methodology to determine the metabolic profile of organic extracts from Malvaviscus arboreus Cav. (Malvaceae), a Mexican plant used in traditional medicine for the treatment of hypertension and other illnesses. Also, we determined the vasorelaxant activity of these extracts by ex vivo rat thoracic aorta assay. Organic extracts of stems and leaves were prepared by a comprehensive maceration process. The vasorelaxant activity was determined by measuring the relaxant capability of the extract to decrease a contraction induced by noradrenaline (0.1 µM). The hexane extract induced a significant vasorelaxant effect in a concentration- and endothelium-dependent manner. Secondary metabolites, such as polyunsaturated fatty acids, terpenes and one flavonoid, were annotated by liquid chromatography/quadrupole time-of-flight mass spectrometry (LC/QTOF-MS) in positive ion mode. This exploratory study allowed us to identify bioactive secondary metabolites from Malvaviscus arboreus, as well as identify potentially-new vasorelaxant molecules and scaffolds for drug discovery.


Subject(s)
Aorta, Thoracic/chemistry , Malvaceae/chemistry , Plant Extracts/metabolism , Vasodilator Agents/metabolism , Animals , Aorta, Thoracic/metabolism , Chromatography, Liquid , Male , Malvaceae/metabolism , Mass Spectrometry , Molecular Structure , Plant Extracts/analysis , Rats , Rats, Wistar , Vasodilator Agents/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...